$LAHO BOFA recently toured the University of Miami Miller School of Medicine Division of Neonatology
..Accompanied by Miller School and Department of Pediatrics leadership, the representatives visited the areas the bank’s donation supported: the Bank of America Molecular and Cell Biology Neonatal Research Lab, and the Schatzi and Stanley Kassal Project: New Born Neonatal Intensive Care Unit (NICU) at Holtz Children’s Hospital at the University of Miami/Jackson Memorial Medical Center.
“We are so pleased that our investment in two of Miami’s anchor organizations 10 years ago continues to yield benefits for our community,” said Gene Schaefer, Miami market president at Bank of America,
..Young’s primary research focus is bronchopulmonary dysplasia and pulmonary hypertension. She has completed all of the pre-clinical work and is hoping to launch the first-ever in-human clinical trial in the U.S. exploring the use of bone-marrow derived mesenchymal stem cells to treat bronchopulmonary dysplasia.
Why so many people are investing their money into stem cell research
Stem cell research has seen a boom in investment in recent years, but why exactly are large corporations just now deciding to invest their hard-earned capital in stem cell research?
Continued Innovation Rapid Advancement
While it is always wise to approach new technology and medical advancements with measured optimism. When corporate powerhouses like Johnson & Johnson begin investing in stem cell research, it can understandably be hard to remain patient.